Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |